ID   ACADM_HUMAN             Reviewed;         421 AA.
AC   P11310; Q5T4U4; Q9NYF1;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1989, sequence version 1.
DT   10-MAY-2017, entry version 199.
DE   RecName: Full=Medium-chain specific acyl-CoA dehydrogenase, mitochondrial;
DE            Short=MCAD;
DE            EC=1.3.8.7;
DE   Flags: Precursor;
GN   Name=ACADM;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=3035565; DOI=10.1073/pnas.84.12.4068;
RA   Kelly D.P., Kim J.-J.P., Billadello J.J., Hainline B.E., Chu T.W.,
RA   Strauss A.W.;
RT   "Nucleotide sequence of medium-chain acyl-CoA dehydrogenase mRNA and
RT   its expression in enzyme-deficient human tissue.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:4068-4072(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=1731887; DOI=10.1021/bi00116a013;
RA   Zhang Z.F., Kelly D.P., Kim J.-J.P., Zhou Y.Q., Ogden M.L.,
RA   Whelan A.J., Strauss A.W.;
RT   "Structural organization and regulatory regions of the human medium-
RT   chain acyl-CoA dehydrogenase gene.";
RL   Biochemistry 31:81-89(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Colon;
RA   Sun F., Wang Y., Block G.D.;
RT   "Medium-chain acyl-CoA dehydrogenase.";
RL   Submitted (MAR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Heart;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 218-235, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, and Cajal-Retzius cell;
RA   Lubec G., Vishwanath V.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 314-342, AND VARIANT ACADMD
RP   GLU-329.
RX   PubMed=2393404; DOI=10.1016/0006-291X(90)91421-N;
RA   Matsubara Y., Narisawa K., Miyabayashi S., Tada K., Coates P.M.,
RA   Bachmann C., Elsas L.J. II, Pollitt R.J., Rhead W.J., Roe C.R.;
RT   "Identification of a common mutation in patients with medium-chain
RT   acyl-CoA dehydrogenase deficiency.";
RL   Biochem. Biophys. Res. Commun. 171:498-505(1990).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-279 AND LYS-301, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   DEACETYLATION BY SIRT3.
RX   PubMed=24121500; DOI=10.1074/jbc.M113.510354;
RA   Bharathi S.S., Zhang Y., Mohsen A.W., Uppala R., Balasubramani M.,
RA   Schreiber E., Uechi G., Beck M.E., Rardin M.J., Vockley J., Verdin E.,
RA   Gibson B.W., Hirschey M.D., Goetzman E.S.;
RT   "SIRT3 regulates long-chain acyl-coA dehydrogenase by deacetylating
RT   conserved lysines near the active site.";
RL   J. Biol. Chem. 288:33837-33847(2013).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   FUNCTION.
RX   PubMed=25416781; DOI=10.1074/jbc.M114.614115;
RA   Malecki J., Ho A.Y., Moen A., Dahl H.A., Falnes P.O.;
RT   "Human METTL20 is a mitochondrial lysine methyltransferase that
RT   targets the beta subunit of electron transfer flavoprotein (ETFbeta)
RT   and modulates its activity.";
RL   J. Biol. Chem. 290:423-434(2015).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) IN COMPLEX WITH FAD AND THE
RP   SUBSTRATE ANALOG OCTANOYL-COENZYME A, COFACTOR, AND SUBUNIT.
RX   PubMed=8823176; DOI=10.1021/bi9607867;
RA   Lee H.J., Wang M., Paschke R., Nandy A., Ghisla S., Kim J.-J.P.;
RT   "Crystal structures of the wild type and the Glu376Gly/Thr255Glu
RT   mutant of human medium-chain acyl-CoA dehydrogenase: influence of the
RT   location of the catalytic base on substrate specificity.";
RL   Biochemistry 35:12412-12420(1996).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 26-421 IN COMPLEXES WITH FAD
RP   AND THE ETFA-ETFB HETERODIMER, MUTAGENESIS OF LEU-86; LEU-98; LEU-100;
RP   ILE-108; GLU-237 AND GLU-384, AND SUBUNIT.
RX   PubMed=15159392; DOI=10.1074/jbc.M404884200;
RA   Toogood H.S., van Thiel A., Basran J., Sutcliffe M.J., Scrutton N.S.,
RA   Leys D.;
RT   "Extensive domain motion and electron transfer in the human electron
RT   transferring flavoprotein.medium chain acyl-CoA dehydrogenase
RT   complex.";
RL   J. Biol. Chem. 279:32904-32912(2004).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) IN COMPLEXES WITH FAD AND THE
RP   ETFA-ETFB HETERODIMER, MUTAGENESIS OF TRP-191; GLU-237 AND GLU-384,
RP   AND SUBUNIT.
RX   PubMed=15975918; DOI=10.1074/jbc.M505562200;
RA   Toogood H.S., van Thiel A., Scrutton N.S., Leys D.;
RT   "Stabilization of non-productive conformations underpins rapid
RT   electron transfer to electron-transferring flavoprotein.";
RL   J. Biol. Chem. 280:30361-30366(2005).
RN   [19]
RP   REVIEW ON VARIANTS ACADMD.
RX   PubMed=1363805; DOI=10.1002/humu.1380010402;
RA   Tanaka K., Yokota I., Coates P.M., Strauss A.W., Kelly D.P.,
RA   Zhang Z.F., Gregersen N., Andresen B.S., Matsubara Y., Curtis D.,
RA   Chen Y.-T.;
RT   "Mutations in the medium chain acyl-CoA dehydrogenase (MCAD) gene.";
RL   Hum. Mutat. 1:271-279(1992).
RN   [20]
RP   VARIANT ACADMD GLU-329.
RX   PubMed=2394825; DOI=10.1172/JCI114761;
RA   Yokota I., Indo Y., Coates P.M., Tanaka K.;
RT   "Molecular basis of medium chain acyl-coenzyme A dehydrogenase
RT   deficiency. An A to G transition at position 985 that causes a lysine-
RT   304 to glutamate substitution in the mature protein is the single
RT   prevalent mutation.";
RL   J. Clin. Invest. 86:1000-1003(1990).
RN   [21]
RP   VARIANT ACADMD GLU-329.
RX   PubMed=2251268; DOI=10.1073/pnas.87.23.9236;
RA   Kelly D.P., Whelan A.J., Ogden M.L., Alpers R., Zhang Z.F., Bellus G.,
RA   Gregersen N., Dorland L., Strauss A.W.;
RT   "Molecular characterization of inherited medium-chain acyl-CoA
RT   dehydrogenase deficiency.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:9236-9240(1990).
RN   [22]
RP   VARIANTS ACADMD ILE-149; ARG-244; ARG-267 AND THR-375.
RX   PubMed=1684086;
RA   Yokota I., Coates P.M., Hale D.E., Rinaldo P., Tanaka K.;
RT   "Molecular survey of a prevalent mutation, 985A-to-G transition, and
RT   identification of five infrequent mutations in the medium-chain Acyl-
RT   CoA dehydrogenase (MCAD) gene in 55 patients with MCAD deficiency.";
RL   Am. J. Hum. Genet. 49:1280-1291(1991).
RN   [23]
RP   VARIANT ACADMD GLU-329.
RX   PubMed=1902818; DOI=10.1007/BF00201539;
RA   Gregersen N., Andresen B.S., Bross P., Winter V., Ruediger N.,
RA   Engst S., Christensen E., Kelly D., Strauss A.W., Koelvraa S.,
RA   Bolund L., Ghisla S.;
RT   "Molecular characterization of medium-chain acyl-CoA dehydrogenase
RT   (MCAD) deficiency: identification of a lys329 to glu mutation in the
RT   MCAD gene, and expression of inactive mutant enzyme protein in E.
RT   coli.";
RL   Hum. Genet. 86:545-551(1991).
RN   [24]
RP   VARIANT ACADMD GLU-329 FREQUENCY.
RX   PubMed=1671131; DOI=10.1016/0140-6736(91)90907-7;
RA   Blakemore A.I., Singleton H., Pollitt R.J., Engel P.C., Kolvraa S.,
RA   Gregersen N., Curtis D.;
RT   "Frequency of the G985 MCAD mutation in the general population.";
RL   Lancet 337:298-299(1991).
RN   [25]
RP   VARIANTS ACADMD THR-326 AND ARG-336.
RX   PubMed=8198141;
RA   Andresen B.S., Jensen T.G., Bross P., Knudsen I., Winter V.,
RA   Koelvraa S., Bolund L., Ding J.-H., Chen Y.-T., van Hove J.L.K.,
RA   Curtis D., Yokota I., Tanaka K., Kim J.-J.P., Gregersen N.;
RT   "Disease-causing mutations in exon 11 of the medium-chain acyl-CoA
RT   dehydrogenase gene.";
RL   Am. J. Hum. Genet. 54:975-988(1994).
RN   [26]
RP   VARIANT ACADMD 115-GLY-CYS-116 DEL.
RX   PubMed=7603790; DOI=10.1203/00006450-199505000-00021;
RA   Ziadeh R., Hoffman E.P., Finegold D.N., Hoop R.C., Brackett J.C.,
RA   Strauss A.W., Naylor E.W.;
RT   "Medium chain acyl-CoA dehydrogenase deficiency in Pennsylvania:
RT   neonatal screening shows high incidence and unexpected mutation
RT   frequencies.";
RL   Pediatr. Res. 37:675-678(1995).
RN   [27]
RP   VARIANT ACADMD ARG-195.
RX   PubMed=7929823; DOI=10.1172/JCI117486;
RA   Brackett J.C., Sims H.F., Steiner R.D., Nunge M., Zimmerman E.M.,
RA   Demartinville B., Rinaldo P., Slaugh R., Strauss A.W.;
RT   "A novel mutation in medium chain acyl-CoA dehydrogenase causes sudden
RT   neonatal death.";
RL   J. Clin. Invest. 94:1477-1483(1994).
RN   [28]
RP   VARIANTS ACADMD TYR-116; ALA-193 AND CYS-352.
RX   PubMed=9158144; DOI=10.1093/hmg/6.5.695;
RA   Andresen B.S., Bross P., Udvari S., Kirk J., Gray G., Kmoch S.,
RA   Chamoles N., Knudsen I., Winter V., Wilcken B., Yokota I., Hart K.,
RA   Packman S., Harpey J.P., Saudubray J.-M., Hale D.E., Bolund L.,
RA   Koelvraa S., Gregersen N.;
RT   "The molecular basis of medium-chain acyl-CoA dehydrogenase (MCAD)
RT   deficiency in compound heterozygous patients: is there correlation
RT   between genotype and phenotype?";
RL   Hum. Mol. Genet. 6:695-707(1997).
RN   [29]
RP   CHARACTERIZATION OF VARIANT ACADMD ALA-193.
RX   PubMed=9882619; DOI=10.1042/bj3370225;
RA   Kuchler B., Abdel-Ghany A.G., Bross P., Nandy A., Rasched I.,
RA   Ghisla S.;
RT   "Biochemical characterization of a variant human medium-chain acyl-CoA
RT   dehydrogenase with a disease-associated mutation localized in the
RT   active site.";
RL   Biochem. J. 337:225-230(1999).
RN   [30]
RP   VARIANTS ACADMD LEU-206 AND GLU-329.
RX   PubMed=10767181; DOI=10.1006/mgme.2000.2978;
RA   Yang B.-Z., Ding J.-H., Zhou C., Dimachkie M.M., Sweetman L.,
RA   Dasouki M.J., Wilkinson J., Roe C.R.;
RT   "Identification of a novel mutation in patients with medium-chain
RT   acyl-CoA dehydrogenase deficiency.";
RL   Mol. Genet. Metab. 69:259-262(2000).
RN   [31]
RP   VARIANTS ACADMD HIS-67; THR-78; ILE-121 AND ARG-310.
RX   PubMed=11349232; DOI=10.1086/320602;
RA   Andresen B.S., Dobrowolski S.F., O'Reilly L., Muenzer J.,
RA   McCandless S.E., Frazier D.M., Udvari S., Bross P., Knudsen I.,
RA   Banas R., Chace D.H., Engel P.C., Naylor E.W., Gregersen N.;
RT   "Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by
RT   MS/MS-based prospective screening of newborns differ from those
RT   observed in patients with clinical symptoms: identification and
RT   characterization of a new, prevalent mutation that results in mild
RT   MCAD deficiency.";
RL   Am. J. Hum. Genet. 68:1408-1418(2001).
RN   [32]
RP   VARIANT ACADMD LEU-245.
RX   PubMed=11409868; DOI=10.1007/s004390100501;
RA   Zschocke J., Schulze A., Lindner M., Fiesel S., Olgemoller K.,
RA   Hoffmann G.F., Penzien J., Ruiter J.P.N., Wanders R.J.A.,
RA   Mayatepek E.;
RT   "Molecular and functional characterization of mild MCAD deficiency.";
RL   Hum. Genet. 108:404-408(2001).
RN   [33]
RP   VARIANTS ACADMD THR-281 AND GLU-329.
RX   PubMed=11486912; DOI=10.1023/A:1010533408635;
RA   Albers S., Levy H.L., Irons M., Strauss A.W., Marsden D.;
RT   "Compound heterozygosity in four asymptomatic siblings with medium-
RT   chain acyl-CoA dehydrogenase deficiency.";
RL   J. Inherit. Metab. Dis. 24:417-418(2001).
RN   [34]
RP   VARIANT [LARGE SCALE ANALYSIS] ARG-132.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Acyl-CoA dehydrogenase specific for acyl chain lengths
CC       of 4 to 16 that catalyzes the initial step of fatty acid beta-
CC       oxidation. Utilizes the electron transfer flavoprotein (ETF) as an
CC       electron acceptor to transfer electrons to the main mitochondrial
CC       respiratory chain via ETF-ubiquinone oxidoreductase (ETF
CC       dehydrogenase). {ECO:0000269|PubMed:25416781}.
CC   -!- CATALYTIC ACTIVITY: A medium-chain acyl-CoA + electron-transfer
CC       flavoprotein = a medium-chain trans-2,3-dehydroacyl-CoA + reduced
CC       electron-transfer flavoprotein.
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:8823176};
CC   -!- PATHWAY: Lipid metabolism; mitochondrial fatty acid beta-
CC       oxidation.
CC   -!- SUBUNIT: Homotetramer. Interacts with the heterodimeric electron
CC       transfer flavoprotein ETF. {ECO:0000269|PubMed:15159392,
CC       ECO:0000269|PubMed:15975918, ECO:0000269|PubMed:8823176}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P11310-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P11310-2; Sequence=VSP_038420;
CC   -!- PTM: Acetylation at Lys-307 and Lys-311 in proximity of the
CC       cofactor-binding sites reduces catalytic activity (By similarity).
CC       These sites are deacetylated by SIRT3. {ECO:0000250}.
CC   -!- DISEASE: Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD)
CC       [MIM:201450]: An inborn error of mitochondrial fatty acid beta-
CC       oxidation which causes fasting hypoglycemia, hepatic dysfunction
CC       and encephalopathy, often resulting in death in infancy.
CC       {ECO:0000269|PubMed:10767181, ECO:0000269|PubMed:11349232,
CC       ECO:0000269|PubMed:11409868, ECO:0000269|PubMed:11486912,
CC       ECO:0000269|PubMed:1363805, ECO:0000269|PubMed:1671131,
CC       ECO:0000269|PubMed:1684086, ECO:0000269|PubMed:1902818,
CC       ECO:0000269|PubMed:2251268, ECO:0000269|PubMed:2393404,
CC       ECO:0000269|PubMed:2394825, ECO:0000269|PubMed:7603790,
CC       ECO:0000269|PubMed:7929823, ECO:0000269|PubMed:8198141,
CC       ECO:0000269|PubMed:9158144, ECO:0000269|PubMed:9882619}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- MISCELLANEOUS: A number of straight-chain acyl-CoA dehydrogenases
CC       of different substrate specificities are present in mammalian
CC       tissues.
CC   -!- SIMILARITY: Belongs to the acyl-CoA dehydrogenase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M16827; AAA51566.1; -; mRNA.
DR   EMBL; M91432; AAA59567.1; -; Genomic_DNA.
DR   EMBL; M91421; AAA59567.1; JOINED; Genomic_DNA.
DR   EMBL; M91422; AAA59567.1; JOINED; Genomic_DNA.
DR   EMBL; M91423; AAA59567.1; JOINED; Genomic_DNA.
DR   EMBL; M91425; AAA59567.1; JOINED; Genomic_DNA.
DR   EMBL; M91426; AAA59567.1; JOINED; Genomic_DNA.
DR   EMBL; M91427; AAA59567.1; JOINED; Genomic_DNA.
DR   EMBL; M91428; AAA59567.1; JOINED; Genomic_DNA.
DR   EMBL; M91429; AAA59567.1; JOINED; Genomic_DNA.
DR   EMBL; M91430; AAA59567.1; JOINED; Genomic_DNA.
DR   EMBL; M91431; AAA59567.1; JOINED; Genomic_DNA.
DR   EMBL; AF251043; AAF63626.1; -; mRNA.
DR   EMBL; AK312629; BAG35514.1; -; mRNA.
DR   EMBL; AL357314; CAI22390.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX06401.1; -; Genomic_DNA.
DR   EMBL; BC005377; AAH05377.1; -; mRNA.
DR   EMBL; M60505; AAB59625.1; -; Genomic_DNA.
DR   CCDS; CCDS44165.1; -. [P11310-2]
DR   CCDS; CCDS668.1; -. [P11310-1]
DR   PIR; A29031; DEHUCM.
DR   RefSeq; NP_000007.1; NM_000016.5. [P11310-1]
DR   RefSeq; NP_001120800.1; NM_001127328.2. [P11310-2]
DR   UniGene; Hs.445040; -.
DR   PDB; 1EGC; X-ray; 2.60 A; A/B/C/D=26-421.
DR   PDB; 1EGD; X-ray; 2.40 A; A/B/C/D=26-421.
DR   PDB; 1EGE; X-ray; 2.75 A; A/B/C/D=26-421.
DR   PDB; 1T9G; X-ray; 2.90 A; A/B/C/D=26-421.
DR   PDB; 2A1T; X-ray; 2.80 A; A/B/C/D=1-421.
DR   PDB; 4P13; X-ray; 1.73 A; A/B/C/D=35-421.
DR   PDBsum; 1EGC; -.
DR   PDBsum; 1EGD; -.
DR   PDBsum; 1EGE; -.
DR   PDBsum; 1T9G; -.
DR   PDBsum; 2A1T; -.
DR   PDBsum; 4P13; -.
DR   ProteinModelPortal; P11310; -.
DR   SMR; P11310; -.
DR   BioGrid; 106552; 50.
DR   DIP; DIP-34281N; -.
DR   IntAct; P11310; 9.
DR   MINT; MINT-3007693; -.
DR   STRING; 9606.ENSP00000409612; -.
DR   DrugBank; DB03415; 3-Thiaoctanoyl-Coenzyme A.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   DrugBank; DB02910; Octanoyl-Coenzyme A.
DR   SwissLipids; SLP:000001334; -.
DR   iPTMnet; P11310; -.
DR   PhosphoSitePlus; P11310; -.
DR   SwissPalm; P11310; -.
DR   BioMuta; ACADM; -.
DR   DMDM; 113017; -.
DR   REPRODUCTION-2DPAGE; IPI00005040; -.
DR   UCD-2DPAGE; P11310; -.
DR   EPD; P11310; -.
DR   MaxQB; P11310; -.
DR   PaxDb; P11310; -.
DR   PeptideAtlas; P11310; -.
DR   PRIDE; P11310; -.
DR   DNASU; 34; -.
DR   Ensembl; ENST00000370841; ENSP00000359878; ENSG00000117054. [P11310-1]
DR   Ensembl; ENST00000420607; ENSP00000409612; ENSG00000117054. [P11310-2]
DR   GeneID; 34; -.
DR   KEGG; hsa:34; -.
DR   UCSC; uc001dgw.6; human. [P11310-1]
DR   CTD; 34; -.
DR   DisGeNET; 34; -.
DR   GeneCards; ACADM; -.
DR   GeneReviews; ACADM; -.
DR   HGNC; HGNC:89; ACADM.
DR   HPA; HPA006198; -.
DR   HPA; HPA026542; -.
DR   MalaCards; ACADM; -.
DR   MIM; 201450; phenotype.
DR   MIM; 607008; gene.
DR   neXtProt; NX_P11310; -.
DR   OpenTargets; ENSG00000117054; -.
DR   Orphanet; 42; Medium chain acyl-CoA dehydrogenase deficiency.
DR   PharmGKB; PA24425; -.
DR   eggNOG; KOG0140; Eukaryota.
DR   eggNOG; COG1960; LUCA.
DR   GeneTree; ENSGT00760000119007; -.
DR   HOGENOM; HOG000131659; -.
DR   HOVERGEN; HBG000224; -.
DR   InParanoid; P11310; -.
DR   KO; K00249; -.
DR   PhylomeDB; P11310; -.
DR   TreeFam; TF105020; -.
DR   BioCyc; MetaCyc:HS04089-MONOMER; -.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   Reactome; R-HSA-77288; mitochondrial fatty acid beta-oxidation of unsaturated fatty acids.
DR   Reactome; R-HSA-77346; Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA.
DR   Reactome; R-HSA-77348; Beta oxidation of octanoyl-CoA to hexanoyl-CoA.
DR   SABIO-RK; P11310; -.
DR   UniPathway; UPA00660; -.
DR   EvolutionaryTrace; P11310; -.
DR   GenomeRNAi; 34; -.
DR   PRO; PR:P11310; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000117054; -.
DR   CleanEx; HS_ACADM; -.
DR   ExpressionAtlas; P11310; baseline and differential.
DR   Genevisible; P11310; HS.
DR   GO; GO:0030424; C:axon; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:LIFEdb.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003995; F:acyl-CoA dehydrogenase activity; IDA:BHF-UCL.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0042802; F:identical protein binding; IDA:BHF-UCL.
DR   GO; GO:0070991; F:medium-chain-acyl-CoA dehydrogenase activity; IDA:BHF-UCL.
DR   GO; GO:0045329; P:carnitine biosynthetic process; IMP:BHF-UCL.
DR   GO; GO:0019254; P:carnitine metabolic process, CoA-linked; IMP:BHF-UCL.
DR   GO; GO:0006635; P:fatty acid beta-oxidation; IMP:UniProtKB.
DR   GO; GO:0033539; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; IDA:UniProtKB.
DR   GO; GO:0051793; P:medium-chain fatty acid catabolic process; IDA:BHF-UCL.
DR   GO; GO:0051791; P:medium-chain fatty acid metabolic process; IDA:BHF-UCL.
DR   GO; GO:0055114; P:oxidation-reduction process; IDA:BHF-UCL.
DR   CDD; cd01157; MCAD; 1.
DR   Gene3D; 1.10.540.10; -; 1.
DR   InterPro; IPR006089; Acyl-CoA_DH_CS.
DR   InterPro; IPR006091; Acyl-CoA_Oxase/DH_cen-dom.
DR   InterPro; IPR009075; AcylCo_DH/oxidase_C.
DR   InterPro; IPR013786; AcylCoA_DH/ox_N.
DR   InterPro; IPR009100; AcylCoA_DH/oxidase_NM_dom.
DR   InterPro; IPR034180; MCAD.
DR   Pfam; PF00441; Acyl-CoA_dh_1; 1.
DR   Pfam; PF02770; Acyl-CoA_dh_M; 1.
DR   Pfam; PF02771; Acyl-CoA_dh_N; 1.
DR   SUPFAM; SSF47203; SSF47203; 1.
DR   SUPFAM; SSF56645; SSF56645; 1.
DR   PROSITE; PS00072; ACYL_COA_DH_1; 1.
DR   PROSITE; PS00073; ACYL_COA_DH_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Direct protein sequencing; Disease mutation; FAD;
KW   Fatty acid metabolism; Flavoprotein; Lipid metabolism; Mitochondrion;
KW   Oxidoreductase; Phosphoprotein; Polymorphism; Reference proteome;
KW   Transit peptide.
FT   TRANSIT       1     25       Mitochondrion.
FT   CHAIN        26    421       Medium-chain specific acyl-CoA
FT                                dehydrogenase, mitochondrial.
FT                                /FTId=PRO_0000000502.
FT   NP_BIND     158    167       FAD. {ECO:0000269|PubMed:8823176}.
FT   NP_BIND     191    193       FAD. {ECO:0000269|PubMed:8823176}.
FT   NP_BIND     306    308       FAD. {ECO:0000269|PubMed:8823176}.
FT   NP_BIND     316    317       FAD. {ECO:0000269|PubMed:8823176}.
FT   NP_BIND     374    378       FAD. {ECO:0000269|PubMed:8823176}.
FT   NP_BIND     403    405       FAD. {ECO:0000269|PubMed:8823176}.
FT   REGION      278    281       Substrate binding.
FT   ACT_SITE    401    401       Proton acceptor.
FT   BINDING     167    167       Substrate; via carbonyl oxygen.
FT   BINDING     216    216       Substrate.
FT   BINDING     402    402       Substrate; via amide nitrogen.
FT   BINDING     413    413       Substrate.
FT   MOD_RES      69     69       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P45952}.
FT   MOD_RES      69     69       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P45952}.
FT   MOD_RES     179    179       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P45952}.
FT   MOD_RES     212    212       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P45952}.
FT   MOD_RES     212    212       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P45952}.
FT   MOD_RES     217    217       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P45952}.
FT   MOD_RES     217    217       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P45952}.
FT   MOD_RES     259    259       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P45952}.
FT   MOD_RES     259    259       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P45952}.
FT   MOD_RES     271    271       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P45952}.
FT   MOD_RES     271    271       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P45952}.
FT   MOD_RES     279    279       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     301    301       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     351    351       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P45952}.
FT   VAR_SEQ      10     10       R -> RCSLQ (in isoform 2).
FT                                {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_038420.
FT   VARIANT      53     53       R -> C (in ACADMD; dbSNP:rs398123072).
FT                                /FTId=VAR_000317.
FT   VARIANT      67     67       Y -> H (in ACADMD; mild;
FT                                dbSNP:rs121434280).
FT                                {ECO:0000269|PubMed:11349232}.
FT                                /FTId=VAR_013698.
FT   VARIANT      78     78       I -> T (in ACADMD; dbSNP:rs398123074).
FT                                {ECO:0000269|PubMed:11349232}.
FT                                /FTId=VAR_015954.
FT   VARIANT     115    116       Missing (in ACADMD).
FT                                {ECO:0000269|PubMed:7603790}.
FT                                /FTId=VAR_000318.
FT   VARIANT     116    116       C -> Y (in ACADMD).
FT                                {ECO:0000269|PubMed:9158144}.
FT                                /FTId=VAR_015955.
FT   VARIANT     121    121       T -> I (in ACADMD; dbSNP:rs121434283).
FT                                {ECO:0000269|PubMed:11349232}.
FT                                /FTId=VAR_015956.
FT   VARIANT     132    132       P -> R (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035716.
FT   VARIANT     149    149       M -> I (in ACADMD; dbSNP:rs121434277).
FT                                {ECO:0000269|PubMed:1684086}.
FT                                /FTId=VAR_000319.
FT   VARIANT     193    193       T -> A (in ACADMD; the thermostability is
FT                                markedly decreased; dbSNP:rs121434279).
FT                                {ECO:0000269|PubMed:9158144,
FT                                ECO:0000269|PubMed:9882619}.
FT                                /FTId=VAR_000320.
FT   VARIANT     195    195       G -> R (in ACADMD; dbSNP:rs121434278).
FT                                {ECO:0000269|PubMed:7929823}.
FT                                /FTId=VAR_000321.
FT   VARIANT     206    206       R -> L (in ACADMD).
FT                                {ECO:0000269|PubMed:10767181}.
FT                                /FTId=VAR_015957.
FT   VARIANT     244    244       C -> R (in ACADMD; dbSNP:rs121434276).
FT                                {ECO:0000269|PubMed:1684086}.
FT                                /FTId=VAR_000322.
FT   VARIANT     245    245       S -> L (in ACADMD; dbSNP:rs121434281).
FT                                {ECO:0000269|PubMed:11409868}.
FT                                /FTId=VAR_013699.
FT   VARIANT     267    267       G -> R (in ACADMD; dbSNP:rs121434274).
FT                                {ECO:0000269|PubMed:1684086}.
FT                                /FTId=VAR_000323.
FT   VARIANT     281    281       R -> T (in ACADMD; mild or benign
FT                                clinical phenotype; dbSNP:rs121434282).
FT                                {ECO:0000269|PubMed:11486912}.
FT                                /FTId=VAR_013700.
FT   VARIANT     310    310       G -> R (in ACADMD; dbSNP:rs747268471).
FT                                {ECO:0000269|PubMed:11349232}.
FT                                /FTId=VAR_015958.
FT   VARIANT     326    326       M -> T (in ACADMD; dbSNP:rs786204631).
FT                                {ECO:0000269|PubMed:8198141}.
FT                                /FTId=VAR_000324.
FT   VARIANT     329    329       K -> E (in ACADMD; most common variant;
FT                                dbSNP:rs77931234).
FT                                {ECO:0000269|PubMed:10767181,
FT                                ECO:0000269|PubMed:11486912,
FT                                ECO:0000269|PubMed:1902818,
FT                                ECO:0000269|PubMed:2251268,
FT                                ECO:0000269|PubMed:2393404,
FT                                ECO:0000269|PubMed:2394825}.
FT                                /FTId=VAR_000325.
FT   VARIANT     336    336       S -> R (in ACADMD).
FT                                {ECO:0000269|PubMed:8198141}.
FT                                /FTId=VAR_000326.
FT   VARIANT     352    352       Y -> C (in ACADMD).
FT                                {ECO:0000269|PubMed:9158144}.
FT                                /FTId=VAR_015959.
FT   VARIANT     375    375       I -> T (in ACADMD; dbSNP:rs121434275).
FT                                {ECO:0000269|PubMed:1684086}.
FT                                /FTId=VAR_000327.
FT   MUTAGEN      86     86       L->M: Strongly reduced rate of electron
FT                                transfer to ETF.
FT                                {ECO:0000269|PubMed:15159392}.
FT   MUTAGEN      98     98       L->W: Strongly reduced rate of electron
FT                                transfer to ETF.
FT                                {ECO:0000269|PubMed:15159392}.
FT   MUTAGEN     100    100       L->Y: Strongly reduced rate of electron
FT                                transfer to ETF.
FT                                {ECO:0000269|PubMed:15159392}.
FT   MUTAGEN     108    108       I->M: Strongly reduced rate of electron
FT                                transfer to ETF.
FT                                {ECO:0000269|PubMed:15159392}.
FT   MUTAGEN     191    191       W->A: Loss of electron transfer to ETF.
FT                                {ECO:0000269|PubMed:15975918}.
FT   MUTAGEN     191    191       W->F: Reduces rate of electron transfer
FT                                to ETF about six-fold.
FT                                {ECO:0000269|PubMed:15975918}.
FT   MUTAGEN     237    237       E->A: Strongly reduced rate of electron
FT                                transfer to ETF.
FT                                {ECO:0000269|PubMed:15159392,
FT                                ECO:0000269|PubMed:15975918}.
FT   MUTAGEN     384    384       E->A: Reduces rate of electron transfer
FT                                to ETF three-fold.
FT                                {ECO:0000269|PubMed:15159392,
FT                                ECO:0000269|PubMed:15975918}.
FT   MUTAGEN     384    384       E->Q: Reduces rate of electron transfer
FT                                to ETF two-fold.
FT                                {ECO:0000269|PubMed:15159392,
FT                                ECO:0000269|PubMed:15975918}.
FT   CONFLICT    356    356       I -> T (in Ref. 3; AAF63626).
FT                                {ECO:0000305}.
FT   STRAND       36     38       {ECO:0000244|PDB:1EGD}.
FT   HELIX        43     58       {ECO:0000244|PDB:4P13}.
FT   HELIX        61     70       {ECO:0000244|PDB:4P13}.
FT   HELIX        75     83       {ECO:0000244|PDB:4P13}.
FT   HELIX        93     95       {ECO:0000244|PDB:4P13}.
FT   HELIX       102    115       {ECO:0000244|PDB:4P13}.
FT   HELIX       117    136       {ECO:0000244|PDB:4P13}.
FT   HELIX       139    145       {ECO:0000244|PDB:4P13}.
FT   HELIX       147    151       {ECO:0000244|PDB:4P13}.
FT   STRAND      155    159       {ECO:0000244|PDB:4P13}.
FT   STRAND      165    167       {ECO:0000244|PDB:4P13}.
FT   HELIX       169    171       {ECO:0000244|PDB:4P13}.
FT   STRAND      175    179       {ECO:0000244|PDB:4P13}.
FT   STRAND      182    193       {ECO:0000244|PDB:4P13}.
FT   TURN        194    197       {ECO:0000244|PDB:4P13}.
FT   STRAND      198    206       {ECO:0000244|PDB:4P13}.
FT   HELIX       215    218       {ECO:0000244|PDB:4P13}.
FT   STRAND      219    225       {ECO:0000244|PDB:4P13}.
FT   STRAND      231    236       {ECO:0000244|PDB:4P13}.
FT   STRAND      239    241       {ECO:0000244|PDB:4P13}.
FT   STRAND      247    258       {ECO:0000244|PDB:4P13}.
FT   HELIX       259    261       {ECO:0000244|PDB:4P13}.
FT   STRAND      262    265       {ECO:0000244|PDB:4P13}.
FT   TURN        266    268       {ECO:0000244|PDB:1EGE}.
FT   HELIX       269    303       {ECO:0000244|PDB:4P13}.
FT   STRAND      309    312       {ECO:0000244|PDB:1EGC}.
FT   HELIX       313    315       {ECO:0000244|PDB:4P13}.
FT   HELIX       317    345       {ECO:0000244|PDB:4P13}.
FT   HELIX       351    376       {ECO:0000244|PDB:4P13}.
FT   HELIX       377    381       {ECO:0000244|PDB:4P13}.
FT   HELIX       387    394       {ECO:0000244|PDB:4P13}.
FT   HELIX       395    398       {ECO:0000244|PDB:4P13}.
FT   STRAND      400    402       {ECO:0000244|PDB:4P13}.
FT   HELIX       404    417       {ECO:0000244|PDB:4P13}.
SQ   SEQUENCE   421 AA;  46588 MW;  7CD0B5832410581B CRC64;
     MAAGFGRCCR VLRSISRFHW RSQHTKANRQ REPGLGFSFE FTEQQKEFQA TARKFAREEI
     IPVAAEYDKT GEYPVPLIRR AWELGLMNTH IPENCGGLGL GTFDACLISE ELAYGCTGVQ
     TAIEGNSLGQ MPIIIAGNDQ QKKKYLGRMT EEPLMCAYCV TEPGAGSDVA GIKTKAEKKG
     DEYIINGQKM WITNGGKANW YFLLARSDPD PKAPANKAFT GFIVEADTPG IQIGRKELNM
     GQRCSDTRGI VFEDVKVPKE NVLIGDGAGF KVAMGAFDKT RPVVAAGAVG LAQRALDEAT
     KYALERKTFG KLLVEHQAIS FMLAEMAMKV ELARMSYQRA AWEVDSGRRN TYYASIAKAF
     AGDIANQLAT DAVQILGGNG FNTEYPVEKL MRDAKIYQIY EGTSQIQRLI VAREHIDKYK
     N
//
